Breaking from AACR: Profiling the TCR Beta Repertoire in NSCLC Donors

TCRβ sequencing is currently being explored in oncology research as a potential predictor for patient response to immunotherapies.   Researchers from Biodesix, Inc. shared their most recent findings in this area at the AACR Advances in Liquid Biopsies conference in Miami from January 13–16, 2020. The research, co-authored by our Benjamin Tjoa, evaluated peripheral blood lymphocytes…

What We Learned at AACR 2019

We all know that CAR-T therapies and immune checkpoint inhibitors are game-changers for oncology, and both were on display at the American Association for Cancer Research’s annual meeting held in Atlanta last week. Although both therapies have produced spectacular results in some patients, neither work for all patients and efforts must now turn to understanding…

Meet Us at PEGS 2018

PEGS: The The Essential Protein Engineering Summit brings the brightest minds in biotherapeutics protein drug development together under one roof! We are thrilled to be attending PEGS 2018 this year in Boston. Attending PEGS? See Us At Booth 201 Be sure to visit us at Booth 201 to see our latest immune cell products and…